A donor's and a recipient's HLA types should match as closely as possible to prevent the recipient's immune system from attacking the donor's marrow as a foreign material that does not belong in the body.
Donors might be especially called to a clinic to provide HLA class I matched platelets for a certain patient.
Further developments in DNA technology now allow technicians to determine a pre- implantation embryo ' s histocompatibility leukocyte antigen (HLA ).
Furthermore, a number of patients never develop HLA antibodies nor do they become refractory, despite receiving multiple platelet transfusions.
Human leuckocyte antigen (HLA)-A group of protein molecules located on bone marrow cells that can provoke an immune response.
Human Leukeocytic Antigens (HLA) molecules are found on the surface of human white blood cells and help to coordinate the immune response.
Human materials HLA reagents prepared from human source material should comply with the guidelines in Section 10.5.
In addition to siblings, another choice is bone marrow from one of the parents, who shares half the affected child's HLA antigens.
In most cases, 1 or more female donors had positive HLA and/or granulocyte antibodies.
In some patients with HLA antibodies, HPA antibodies may also be present requiring donor platelets matched for both type of antibodies.
Lecendreux, M., et al. "HLA and genetic susceptibility to sleepwalking."
Subacute cutaneous lupus erythematosus is a mild overlap form associated with HLA DR3 and anti-Ro antibodies.
The closer the HLA match between a bone marrow donor and recipient, the lower the chances that the recipient's body will reject the transplanted tissue.
The specificity of the antibodies will be determined by panel studies with HLA typed donor lymphocytes and HNA typed donor granulocytes.
They will be tissue-typed to determine whether their bone marrow has the same human leukocyte antigens (HLA) as the affected child.
This has allowed for the typing of HLA serological antigen specificities.
Thus ANN tools could be used for improved donor kidney allocation and for exploring the role of HLA in transplant rejection.
We thus found a high frequency of allele-specific and locus-specific down-regulation of HLA expression in uveal melanoma cell lines.